Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gabrielli

Showing results (171-180 of 424) with videos related to

Pageof 43
Sort By:
Annals of the Rheumatic Diseases|May 15, 2001
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexesG Valentini, A Della Rossa, S Bombardieri, et al.
Annals of the Rheumatic Diseases|May 17, 2011
Preliminary classification criteria for the cryoglobulinaemic vasculitisS De Vita, F Soldano, M Isola, et al.
European Journal of Physical and Rehabilitation Medicine|January 26, 2021
Development and implementation of a stroke rehabilitation integrated care pathway in an Italian no profit institution: an observational studyFrancesca Cecchi, Manuela Diverio, Chiara Arienti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Scandinavian Journal of Rheumatology|October 10, 2017
There is a need for new systemic sclerosis subset criteria. A content analytic approachS R Johnson, M L Soowamber, J Fransen, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Physical Review Letters|March 3, 2023
Measurement of the Λ_{c}^{+} LifetimeF Abudinén, L Aggarwal, H Ahmed, et al.
Physical Review Letters|August 18, 2023
Test of Light-Lepton Universality in the Rates of Inclusive Semileptonic B-Meson Decays at Belle IIL Aggarwal, H Ahmed, H Aihara, et al.
Physical Review Letters|November 13, 2023
Precise Measurement of the D_{s}^{+} Lifetime at Belle III Adachi, L Aggarwal, H Aihara, et al.
Pageof 43

Showing results (171-180 of 424) with videos related to

Sort By:
Pageof 43
Annals of the Rheumatic Diseases|May 15, 2001
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexesG Valentini, A Della Rossa, S Bombardieri, et al.
Annals of the Rheumatic Diseases|May 17, 2011
Preliminary classification criteria for the cryoglobulinaemic vasculitisS De Vita, F Soldano, M Isola, et al.
European Journal of Physical and Rehabilitation Medicine|January 26, 2021
Development and implementation of a stroke rehabilitation integrated care pathway in an Italian no profit institution: an observational studyFrancesca Cecchi, Manuela Diverio, Chiara Arienti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Scandinavian Journal of Rheumatology|October 10, 2017
There is a need for new systemic sclerosis subset criteria. A content analytic approachS R Johnson, M L Soowamber, J Fransen, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Physical Review Letters|March 3, 2023
Measurement of the Λ_{c}^{+} LifetimeF Abudinén, L Aggarwal, H Ahmed, et al.
Physical Review Letters|August 18, 2023
Test of Light-Lepton Universality in the Rates of Inclusive Semileptonic B-Meson Decays at Belle IIL Aggarwal, H Ahmed, H Aihara, et al.
Physical Review Letters|November 13, 2023
Precise Measurement of the D_{s}^{+} Lifetime at Belle III Adachi, L Aggarwal, H Aihara, et al.
Pageof 43